Assessing public economic gains from expanding HPV vaccination in Portugal: a governmental perspective analysis

Nikolaos Kotsopoulos; Mark P. Connolly; Andrew Pavelyev; Bernardo Rodrigues; Joana Silva; Ugne Sabale

doi:10.1080/13696998.2026.2617010

January 29, 2026Journal of Medical EconomicsOpen Access

Assessing public economic gains from expanding HPV vaccination in Portugal: a governmental perspective analysis

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to evaluate the economic benefits of extending HPV vaccination to adults in Portugal.
Analyzed current vaccination strategies
Assessed potential economic gains from expanded vaccination
Compared expenditures against health outcomes
Economic gains from expanded vaccination are likely higher than costs
Public health benefits translate to significant macroeconomic impacts
Adult vaccination can contribute positively to fiscal health in Portugal

Implication

Economic analysis reveals potential health benefits translating to fiscal gains in Portugal's adult population.

Abstract

Expanding HPV vaccination to adult populations up to 26 years of age likely offers additional economic gains that exceed expenditures when compared to the current vaccination strategy, translating public health benefits of vaccination strategies into macroeconomic and fiscal outcomes for Portugal.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kotsopoulos et al. (2026) studied this question.

synapsesocial.com/papers/6980fbf6c1c9540dea80dcba https://doi.org/10.1080/13696998.2026.2617010

View Full Paper

Ask AI

Bookmark

Share

Assessing public economic gains from expanding HPV vaccination in Portugal: a governmental perspective analysis

Key Points

Implication

Abstract

Discussion

Cite This Study

Assessing public economic gains from expanding HPV vaccination in Portugal: a governmental perspective analysis

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading